Pity the glycan. A lab has created these very tools by commandeering simple, single-celled microorganisms – namely E. coli bacteria – and engineering them to explore the complex process of glycosylation and the functional role that protein-linked glycans play in health and disease.
Click here for original story, Engineered bacteria churn out cancer biomarkers
Source: ScienceDaily